Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 11/20 | 0.72 |
| ▸ | KMT2A | Q03164 | 10/20 | 0.72 |
| ▸ | MEN1 | O00255 | 9/20 | 0.72 |
| ▸ | MAPT | P10636 | 8/20 | 0.72 |
| ▸ | LMNA | P02545 | 4/20 | 0.72 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.72 |
| ▸ | MCL1 | Q07820 | 3/20 | 0.68 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.67 |
| ▸ | NPC1 | O15118 | 3/20 | 0.67 |
| ▸ | USP2 | O75604 | 2/20 | 0.67 |
| ▸ | RAB9A | P51151 | 2/20 | 0.67 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.67 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.66 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.66 |
| ▸ | ESR1 | P03372 | 1/20 | 0.58 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.54 |
| ▸ | PKM | P14618 | 1/20 | 0.54 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.50 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.50 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10085969 | 0.87 | KMT2A (0.87) | GAAKMT2AMEN1MAPTLMNA | |
| SCHEMBL10086015 | 0.85 | KMT2A (0.84) | GAAKMT2AMEN1MAPTLMNA | |
| SCHEMBL3395971 | 0.84 | KMT2A (1.00) | GAAKMT2AMEN1MAPTLMNA | |
| Hydrochloric Acid SCHEMBL11862709 | 0.83 | KMT2A (0.97) | GAAKMT2AMEN1MAPTLMNA | |
| SCHEMBL11273709 | 0.82 | KMT2A (0.64) | GAAKMT2AMEN1MAPTLMNA | |
| SCHEMBL15018298 | 0.82 | KMT2A (0.77) | GAAKMT2AMEN1MAPTLMNA | |
| SCHEMBL4171644 | 0.81 | GAA (1.00) | GAAKMT2AMEN1MAPTLMNA | |
| SCHEMBL10084925 | 0.81 | KMT2A (0.70) | GAAKMT2AMEN1MAPTLMNA | |
| SCHEMBL11279534 | 0.80 | KMT2A (0.74) | GAAKMT2AMEN1MAPTLMNA | |
| SCHEMBL11874703 | 0.80 | KMT2A (0.74) | GAAKMT2AMEN1MAPTLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2313472-B1 | AZAPYRENES FOR ELECTRONIC APPLICATIONS | BASF SE (DE) | 2012-08-15 | — | — | EP | disclosed |
| US-8193528-B2 | Azapyrenes for electronic applications | BASF SE (DE) | 2012-06-05 | — | — | US | disclosed |
| US-20110186821-A1 | AZAPYRENES FOR ELECTRONIC APPLICATIONS | BASF SE (DE) | 2011-08-04 | — | — | US | disclosed |
| WO-2010006890-A1 | AZAPYRENES FOR ELECTRONIC APPLICATIONS | BASF SE (DE) | 2010-01-21 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110186821-A1 | AZAPYRENES FOR ELECTRONIC APPLICATIONS | RPS4Y1, NPY4R, XPO4 | GAA 3910/4885KMT2A 3407/4885MEN1 388/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.